The latest updates on our research and how it is improving people’s lives.
27 July 2020
The collaboration brings the European Health Data & Evidence Network (EHDEN) together with the European Medicines Agency and partners.
24 July 2020
Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care.
23 July 2020
The University of Oxford has awarded the title of Associate Professor to seven senior researchers at NDORMS, and three University Research Lecturer titles.
23 July 2020
Stay-at-home parents, cleaners, and blue-collar workers found to be more likely to develop osteoarthritis
1 July 2020
Professor Mark Coles was recently appointed to the governing body of the University’s newest graduate college.
29 June 2020
The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.
22 June 2020
Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.
18 June 2020
Reporting at EULAR, researchers found that opioid use by patients with rheumatic and musculoskeletal pain was on the rise in Europe.
17 June 2020
Christopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.
16 June 2020
The Capture the Fracture Partnership aims to prevent 250 million fractures by 2025 and combat the global public health burden of osteoporosis.
11 June 2020
Sion Glyn-Jones and Matt Costa are members of the Covid 19 Urgent Public Health Group coordinating trials to address health impacts of the pandemic.
10 June 2020
NDORMS Professor Duncan Richards and Dr Matt Rowland (Nuffield Department of Clinical Neurosciences) are leading the Oxford arm of a new UK trial to investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
8 June 2020
The statistical analysis and reporting of treatment effects in reports of randomised trials with a binary primary endpoint requires substantial improvement, suggests NDORMS research published in BMC Medicine.
5 June 2020
A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient.
4 June 2020
Research at the Kennedy Institute reveals sub-populations of stromal cells with distinct functions in human fibrotic disease. These findings could inform development of more specific therapies with fewer off-target effects.
23 May 2020
Published in Science Immunology, researchers at the Kennedy Institute have identified the role of IRF5 in controlling intestinal inflammation.
14 May 2020
The research will test innovative technology that harnesses the body’s intrinsic immune system to transform the treatment of cancer and autoimmune diseases.